Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm

Pathology Research and Practice

Volumn 205, Issue 2, 2009, Pages 83-87

  Tabriz, H Moradi ^a   Adabi, Kh ^b   Lashkari, A ^b   Heshmat, R ^b   Haghpanah, V ^b   Larijani, B ^b   Tavangar, S M ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Follicular neoplasm; Immunohistochemistry; nm23; Papillary carcinoma; Thyroid

Indexed keywords

NUCLEOSIDE DIPHOSPHATE KINASE A;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; RISK ASSESSMENT; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR VOLUME;

ADENOCARCINOMA, FOLLICULAR; ADENOCARCINOMA, PAPILLARY; ADENOMA; CROSS-SECTIONAL STUDIES; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 58249112850     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2008.08.007     Document Type: Article

References (15)

1. Arai T., Yamashita T., Urano T., et al. Preferential reduction of nm23-H1 gene products in metastatic tissue from papillary and follicular carcinoma of thyroid. Mod. Pathol. 8 (1995) 252-256
2. Bertheau P., De La Rosa A., Steeg P.S., et al. NM23 protein in neoplastic and nonneoplastic thyroid tissues. Am. J. Pathol. 145 (1994) 26-32
3. Bevilacqua G., Sobel M.E., Liotta L.A., et al. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res. 49 (1989) 5185-5190
4. Boix L., Bruix J., Campo E., et al. Nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma. Gastroenterology 107 (1994) 486-491
5. Caligo M.A., Grammatico P., Cipollini G., et al. A low NM23.H1 gene expression identifying high malignancy human melanomas. Melanoma Res. 4 (1994) 179-184
6. Farley D.R., Eberhardt N.L., Grant C.S., et al. Expression of a potential metastasis suppressor gene (nm23) in thyroid neoplasms. World J. Surg. 17 (1993) 615-620
7. Ferenc T., Lewinski A., Lange D., et al. Analysis of nm23-H1 protein immunoreactivity in follicular thyroid tumors. Pol. J. Pathol. 55 (2004) 149-153
8. Fournier H.N., Albiges-Rizo C., and Block M.R. New insights into Nm23 control of cell adhesion and migration. J. Bioenerg. Biomembr. 35 (2003) 81-87
9. Igawa M., Urakami S., Shiina H., et al. Association of nm23 protein levels in human prostates with proliferating cell nuclear antigen expression at autopsy. Eur. Urol. 30 (1996) 383-387
10. Kapitanovic S., Spaventi R., Vujsic S., et al. Nm23-H1 gene expression in ovarian tumors - a potential tumor marker. Anticancer Res. 15 (1995) 587-590
11. Luo W., Matsuo K., Nagayama Y., et al. Immunohistochemical analysis of expression of nm23-H1/nucleoside diphosphate kinase in human thyroid carcinomas: lack of correlation between its expression and lymph node metastasis. Thyroid 3 (1993) 105-109
12. Royds J.A., Silcocks P.B., Rees R.C., et al. Nm23 protein expression in thyroid neoplasms. Pathologica 86 (1994) 240-243
13. Wakimoto N., Yokoyama A., Okabe-Kado J., et al. Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia. Br. J. Cancer 77 (1998) 2298-2303
14. Zafon C., Obiols G., Castellvi J., et al. Nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 86 (2001) 3975-3980
15. Zou M., Shi Y., al-Sedairy S., et al. High levels of Nm23 gene expression in advanced stage of thyroid carcinomas. Br. J. Cancer 68 (1993) 385-388